Page results
-
Our nationally-recognised service helps children and young people (up to 19 years) with type 1 diabetes, type 2 diabetes, monogenic diabetes such as maturity onset diabetes in the young (MODY) and steroid related diabetes.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
Care in the last days of life: information for families, friends and carers.
-
Join in our reflective heart Christmas 2020 campaign! Every year, supporters, staff and friends of UCLH Charity write a message of thanks, celebration or remembrance on a reflective heart together with a donation.
-
Patient information for patients suffering from long COVID who are returning to work.
-
This page provides information for patients following a Gastric Bypass/Sleeve Gastrectomy.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
File results
-
FOI/2021/0332 - Trust Policy for Information Governance
-
FOI/2021/0333 - Mental health patient complaints
-
FOI/2021/0339 - Defibrotide for the treatment of hepatic veno-occlusive disease
-
FOI/2021/0341 - Total hospital deaths (all causes)
-
FOI/2021/0343 - Hospital admissions and deaths
-
FOI/2021/0345 - Maternity unit closures
-
FOI/2021/0349 - Cancer treatment
-
FOI/2021/0351 - Patients brought to A&E presenting complaint related to mental health
-
FOI/2021/0353 - Operational Pressures Escalation Levels (OPEL) Policy
-
FOI/2021/0363 - Robot assisted laparascopic prostatectomy cost